Physician

Genevieve Lynn Everett-Sigwalt, M.D.

According to 2025 Medicare claims, Genevieve Everett-Sigwalt, M.D. (NPI: 1275736415) practices cardiology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is UPMC ALTOONA REGIONAL HEALTH SERVICES, INC (NPI: 1639158488; TIN: 251219302) and primary practice location at 16601-4804. Everett-Sigwalt is affiliated with the AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Everett-Sigwalt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 2,350 HCPCS/CPT codes, and received $125,484 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,932 prescription claims across 374 beneficiaries totaling $500,330 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 47 records totaling $3,506. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $140,081 and ending at $125,484. Concurrently, Part D prescription costs have risen steadily, from $52,904 to $500,330. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,160	2,248	$140,081
2016	932	1,674	$95,012
2017	1,039	1,938	$94,722
2018	1,171	2,366	$100,221
2019	1,220	2,737	$124,688
2020	1,101	2,539	$111,671
2021	987	2,233	$115,083
2022	645	1,997	$164,343
2023	833	2,546	$169,983
2024	735	2,350	$125,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	776	$52,904
2016	164	887	$92,150
2017	214	1,234	$142,828
2018	268	1,811	$235,670
2019	315	2,087	$357,671
2020	439	3,000	$555,764
2021	544	3,578	$727,975
2022	418	1,867	$392,697
2023	379	2,024	$535,982
2024	374	1,932	$500,330

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	144	170	$84
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	94	235	$20
93228	Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional	135	135	$19
93244	Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days	94	97	$17
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	132	330	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	318	16,127	$295,962
Entresto	Sacubitril/Valsartan	43	2,805	$59,383
Xarelto	Rivaroxaban	64	3,369	$58,309
Jardiance	Empagliflozin	23	1,350	$24,025
Dofetilide	Dofetilide	55	2,702	$17,848

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$3,506	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Genevieve Lynn Everett-Sigwalt, M.D.?

Tedicare shows public-source Medicare data for Genevieve Lynn Everett-Sigwalt, M.D. (NPI 1275736415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Genevieve Lynn Everett-Sigwalt, M.D. have ACO affiliation data?

Genevieve Lynn Everett-Sigwalt, M.D. is shown with ACO affiliation data for AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Genevieve Lynn Everett-Sigwalt, M.D.?

Genevieve Lynn Everett-Sigwalt, M.D. is linked to UPMC ALTOONA REGIONAL HEALTH SERVICES, INC (billing NPI 1639158488) in the available physician profile data.

Does Genevieve Lynn Everett-Sigwalt, M.D. have Open Payments data?

Genevieve Lynn Everett-Sigwalt, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.